創信國際(00676.HK)探索將工廠遷往東南亞可能性
創信國際(00676.HK)公布,新型肺炎的全球性爆發及中美之間的貿易戰為消費者市場帶來了前所未有的挑戰,進而嚴重影響製鞋業務。鑒於對中國出口的鞋類產品徵收的關稅以及新型肺炎的全球性爆發,儘管公司管理層為擴大客戶基礎付出了巨大的努力,惟結果不盡人意,公司將於新型肺炎疫情得到控制時,探索將工廠遷往東南亞的可能性。公司亦將繼續尋找新客戶,並與現有客戶一起探索商機。
公司表示,已於去年開始將位於中國的閒置工廠出租予獨立第三方,租賃業務使公司能夠利用其現有資源創造穩定的收入來源,公司將繼續物色新租賃客戶。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.